JGH: Analysis of the efficacy of hemostatic powder TC-325 in the treatment of upper gastrointestinal bleeding associated with malignant tumors

Tumor-associated upper digestive tract (UGI) bleeding bleeding accounts for 5% of all UGI, which can occur in various ways, kinetic damage from acute to chronic bleeding blood low volume, can cause local tumor invasion of vascular bleeding after injury
.

Endoscopy is the first-line treatment.

Tumor-associated upper digestive tract (UGI) bleeding bleeding accounts for 5% of all UGI, which can occur in various ways, kinetic damage from acute to chronic bleeding blood low volume, can cause local tumor invasion of vascular bleeding after injury

 

The researchers prospectively collected data on the use of TC-325 from 17 medical centers in Europe
.

TC-325 to use during emergency endoscopy, an endoscope according to the judgment of the physician, for secondary tumor digestive tract bleeding or the use of TC-325 standard hemostatic spurting art dual therapy or salvage therapy

Digestion

 

A total of 105 patients with upper gastrointestinal bleeding secondary to tumor damage were recruited in this study
.

The median Blatchford score at baseline was 10 (interquartile range [IQR], 7-12)

 

This study confirms that TC-325 hemostatic powder achieves a high rate of immediate hemostasis in the digestive tract, but the rate of rebleeding after the treatment of tumor-related upper gastrointestinal bleeding is equivalent, but the use of TC-325 can help improve the blood transfusion of these patients Demand
.

This study confirms that TC-325 hemostatic powder achieves a high rate of immediate hemostasis in the digestive tract, but the rate of rebleeding after the treatment of tumor-related upper gastrointestinal bleeding is equivalent, but the use of TC-325 can help improve the blood transfusion of these patients Demand
.

 

 

Original source:

Mohamed Hussein.

Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes.
Leave a message here